Nirmatrelvir/ritonavir as a possible treatment for Long-COVID. | Rev Esp Quimioter;36(5): 545-546, 2023 10. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Nirmatrelvir/ritonavir as a possible treatment for Long-COVID.

Pérez Catalán, I; Gascón Buj, A; García Muñoz, S; Gómez Alfaro, I; Roig Martí, C; Torres García, M; Reig Valero, R; Ferrando Piqueres, R; Mateu Campos, L; Ramos Rincón, J M; Usó Blasco, J.

Affiliation

Roig Martí C; Celia Roig Martí, Internal Medicine, General University Hospital of Castellón, Castellón de la Plana, Spain. celia.roig.marti@gmail.com.

Rev Esp Quimioter ; 36(5): 545-546, 2023 10.

Article in En | MEDLINE | ID: mdl-37357766

Subject(s)
Key words

COVID-19; Post-Acute COVID-19 Syndrome; SARS-CoV-2; combination; nirmaltrevir; ritonavir

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ritonavir / COVID-19 Limits: Humans Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ritonavir / COVID-19 Limits: Humans Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article